ALDH1A1 and neoplasm: Interestingly, when PIP was combined with DOX, an additional suppression was observed resulting in a 56% reduction in ALDH-1 immunohistochemical expression and a 67% reduction in its levels in tumor homogenates, relative to DOX treatment alone.